MHRA Issues New Guidance for Exporters for a ‘No-Deal’ Scenario

Drug Industry Daily
A A
British regulators will continue to issue EU-required Certificates of Pharmaceutical Product (CPPs) even if there is no formal Brexit agreement, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said on Monday.

To View This Article:

Login

Subscribe To Drug Industry Daily